MedPath

Effects of Duloxetine on muscle loss associated with knee arthrosis

Not Applicable
Conditions
Osteoarthritis
Sarcopenia
Registration Number
RBR-9c72hyz
Lead Sponsor
Sociedade Brasileira de Reumatologia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Osteoarthritis; Pain>7 (visual analog scale); Low/moderate physical performance

Exclusion Criteria

Contra-indications to study's interventions; Inability to walk

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate an increase on physical performance by Short Physical Performance Battery in 12 weeks, by observing a variation of at least 0.8 between pre and post-intervention measures. <br>
Secondary Outcome Measures
NameTimeMethod
Muscle mass assessed by appendicular skeletal muscle mass index on dual-energy X-ray absorptiometry ;Muscle strength assessed by maximal isometric voluntary contraction on knee extensor chair<br><br>
© Copyright 2025. All Rights Reserved by MedPath